Advertisement

International Journal of Hematology

, Volume 80, Issue 3, pp 295–296 | Cite as

Genetic Polymorphism of the CYP2C9 Subfamily of 3 Different Races in Warfarin Maintenance Dose

  • Gin Gin Gan
  • Alan Teh
  • Vijaya Sangkar
  • Maude Elvira Phipps
  • Chee Seng Ku
Letter to the Editor

Keywords

Warfarin International Normalize Ratio Warfarin Dose Rheumatic Heart Disease International Normalize Ratio Range 

References

  1. 1.
    Aithal GP, Day CP, Kersteven PJL, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 1999;27: 717–719.CrossRefGoogle Scholar
  2. 2.
    Takayashi H, Hirotoshi E. Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharmacokinet. 2001;40: 587–603.CrossRefGoogle Scholar
  3. 3.
    Blann A, Hewitt J, Siddiqui F, Bareford D. Racial background is a determinant of average warfarin dose required to maintain INR between 2.0 and 3.0. Br J Haematol. 1999;107:207–209.CrossRefPubMedGoogle Scholar
  4. 4.
    Gan GG, Teh A, Goh KY, Chong HT, Pang KW. Racial background is a determinant factor in the maintenance dosage of warfarin. Int J Haematol. 2003;78:84–86.CrossRefGoogle Scholar
  5. 5.
    Sullivan-Klose TH, Ghanayem BI, Bell DA, et al. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics. 1996;6:341–349.CrossRefPubMedGoogle Scholar
  6. 6.
    Stubbins MJ, Harries LW, Smith G, Tarbit MH,Wolf CR. Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics. 1996;5:429–439.CrossRefGoogle Scholar
  7. 7.
    Takahashi H, Wilkinson GR, Caraco Y, et al. Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients. Clin Pharmacol Ther. 2003;73: 253–263.CrossRefPubMedGoogle Scholar
  8. 8.
    Wang SL, Huang JD, Lai MD, Tsai JJ. Detection of CYP2C9 polymorphisms based on the polymerase chain reaction in Chinese. Pharmacogenetics. 1995;5:37–42.CrossRefPubMedGoogle Scholar
  9. 9.
    LeungAYH, Chow HCH, Kwong YL, et al. Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients. Blood. 2001;98:2584–2587.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Gin Gin Gan
    • 1
  • Alan Teh
    • 1
  • Vijaya Sangkar
    • 1
  • Maude Elvira Phipps
    • 2
  • Chee Seng Ku
    • 2
  1. 1.Department of MedicineFaculty of Medicine, University MalayaLembah PantaiMalaysia
  2. 2.Department of Molecular Medicine, Faculty of MedicineUniversity MalayaMalaysia

Personalised recommendations